WHO ICTRP trial

A study exploring whooping cough protection in infants following vaccination

ISRCTN17271364 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN17271364
Public title A study exploring whooping cough protection in infants following vaccination
Scientific title A randomised, open label study, exploring the differences in immunogenicity and reactogenicity of infants after immunisation with either an acellular (aP) or whole cell pertussis (wP) vaccine
Primary sponsor University of Oxford
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Interventional
Phase Phase III
Countries England;United Kingdom
Conditions Response to pertussis (whooping cough) vaccination in infants Infections and Infestations
Interventions The study will recruit a total of 114 infants and randomise 1:1 to receive either wP or aP at 2 and 4 months of age (primary immunisations). The randomisation lists will be generated by the study statistician using block randomisation. All…
Registration date Sep 3, 2020
Target size 114
Secondary IDs 2019-001789-13;Nil known;CPMS 43441, IRAS 218431
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations